Need help? Write to us [email protected]
Experience the Magic of FillersFairy – Shop Now for Your Beautiful Surprise!
+1(912)5047648
Quick Answer
Lipovela is a two-product PPC/DC lipolysis line from South Korea designed to help clinics separate body and facial contouring workflows. Lipovela Body uses a larger 10 ml format for broader treatment areas. Lipovela V uses a smaller 5 ml format and builds on the same shared base with an extended skin-brightening and conditioning complex — headlined by its glutathione brightening positioning — for face-focused V-line work. Both are ready-to-use liquids with no reconstitution required, allowing clinics to build body and V-line services around one product family.

Body and facial contouring place different demands on product volume, treatment planning, and patient expectations. Body areas — abdomen, flanks, upper arms, thighs — have thicker subcutaneous fat layers and tolerate larger injection volumes across wider surfaces. The face is the opposite: thinner fat layer, more delicate anatomy, and a patient who will notice changes to the skin over the treated zone as the fat underneath reduces.
Lipovela addresses this commercially with two dedicated formats rather than asking clinics to use one vial size for every area. The Body format provides the volume a trunk-and-limb programme requires. The V format provides a smaller vial with an extended skin-conditioning complex, positioned specifically for submental and jawline contouring where clinics often need to consider both localized fat and the appearance of the overlying skin.
The two products share a substantial common ingredient base — the differences between them are additions, not substitutions.
Both Lipovela Body and V are built on high-purity phosphatidylcholine (PPC) and sodium deoxycholate as the primary lipolytic agents. Both include L-Carnitine and B vitamins to support fat metabolism and clearance. Both include cell growth factors (EGF, FGF, IGF), peptides, antioxidants — including glutathione — and skin-support compounds intended to help maintain elasticity during the fat-reduction process. And both are supplied as ready-to-use liquids: no reconstitution, no mixing, no advance preparation.
This shared core means the lipolytic approach is the same across both products. The PPC/DC combination is positioned to support localized fat reduction, with deoxycholate contributing to adipocyte membrane disruption and a subsequent inflammatory clearance response. L-Carnitine and B vitamins are included to support metabolic processing of released lipids. Growth factors and peptides are intended to help maintain the skin over the treatment zone as the underlying fat reduces.
With a shared ingredient base this broad — including glutathione in both — the question is: why stock the V separately?
Two things: an extended skin-conditioning complex and a face-appropriate format.
Lipovela V builds on the shared base with additional ingredients that Body does not include: thioredoxin and superoxide dismutase (SOD) for enhanced antioxidant protection, acetyl hexapeptide-8 for wrinkle management, and proprietary botanical complexes (Naturotics Plus, MultiEx BSASM Plus) for soothing and anti-inflammatory support. While both formulations contain glutathione, V positions glutathione brightening as its headline clinical benefit — making it the centerpiece of the facial-brightening story rather than one ingredient among many.
This broader skin-support profile is designed to complement facial contouring, where clinics commonly consider both localized fat and the appearance of the overlying skin. For facial work — particularly in the highly visible submental and jawline zones — the V formulation gives the clinic a clearer product story and patient communication angle compared to repurposing the body product.
The format difference is practical: V uses 5 ml vials (10 per box), sized for facial treatments where total injection volume per session is lower. Body uses 10 ml vials (10 per box), sized for broader trunk and limb areas. Using the right vial size for the job reduces waste and keeps per-treatment costs predictable.
| Spec | Body | V (Face) |
|---|---|---|
| Vial size | 10 ml | 5 ml |
| Box quantity | 10 vials | 10 vials |
| PPC/DC core | High-purity phosphatidylcholine + sodium deoxycholate (shared) | |
| L-Carnitine + B vitamins | Both (B2, B3, B12) | |
| Growth factors (EGF, FGF, IGF) | Both | |
| Glutathione | Present (as antioxidant) | Present + positioned as headline brightening feature |
| Extended skin complex (V-only) | — | Thioredoxin, SOD, Acetyl Hexapeptide-8, Naturotics Plus, MultiEx BSASM Plus |
| Treatment areas | Abdomen, flanks, arms, thighs, bra line, hips | Double chin, jawline, cheeks, neck |
| Format | Ready-to-use liquid — no reconstitution | |
| Storage | Room temperature, protected from light | |
| Origin | South Korea | |
Sodium deoxycholate is a bile salt the body already produces to emulsify dietary fat. When injected into the subcutaneous fat layer, it contributes to disrupting adipocyte membranes. Phosphatidylcholine supports the emulsification of released lipids, and L-Carnitine is included to help transport freed fatty acids toward metabolic clearance.
Swelling, warmth, and firmness are common expected responses after PPC/DC treatment and reflect the local inflammatory clearance process. Their intensity and duration vary between patients and treatment areas. Because the body clears the disrupted fat cells gradually through normal metabolic pathways, visible fat reduction develops over weeks rather than appearing immediately.
For body treatments, swelling commonly lasts several days. For facial treatments, duration is similar but swelling is more noticeable — scheduling a session ahead of a quiet weekend helps manage patient expectations. The growth factors and skin-support ingredients shared across both formulations are intended to help the overlying skin maintain elasticity during this process, with the V formulation’s extended complex designed to provide additional support in the more delicate facial zone.
Both formulations are ready-to-use liquids — draw directly from the vial into the syringe. No reconstitution step, no standing time. This reduces preparation-related variability and simplifies the treatment workflow compared to products that require mixing or hydration before use.
Injection is into the subcutaneous fat layer. Treatment area mapping, injection technique, and volume per treatment follow clinical assessment and the product’s supplied instructions.
Patient selection is the single most important factor in outcome quality. Lipovela is positioned for localized fat reduction in patients at or near their target weight — it is a contouring treatment, not a weight-loss solution. Patients with soybean allergies cannot receive PPC-containing products. Other standard contraindications: active infection or inflammation in the treatment area, pregnancy, breastfeeding. Do not inject intramuscularly or intravenously. Do not use below the knees. Do not mix with other solutions.
For clinics offering both body contouring and facial slimming services, the two-SKU system creates a simpler stocking model: one larger format for body programmes and one smaller, face-positioned formula for V-line treatments. This can streamline ordering, staff education, and patient menu design.
Volume efficiency. Body treatments across the abdomen and flanks consume product quickly — the 10 ml vial is sized for this. Facial treatments use less product per session — the 5 ml vial avoids the waste of cracking open a large body vial for a small-area treatment.
Menu differentiation. Having a dedicated facial product — with its own ingredient story around glutathione brightening and a more complete skin-conditioning complex — gives the clinic a clear way to present V-line services as a separate, premium offering rather than repurposing the body product for the face. The V formulation’s extended ingredient profile supports a stronger patient conversation about skin quality alongside fat reduction.
Ready-to-use workflow. No reconstitution across either product means fewer preparation steps, faster setup, and reduced preparation-related variability between sessions. For clinics running high-volume contouring days, this is a meaningful time and consistency advantage.
Room-temperature storage. Neither product requires refrigeration, which eliminates cold-chain logistics and frees up clinic fridge space. Store both formulations at room temperature, protected from light.
Cross-selling. Patients who start with one product often become interested in the other. A body contouring patient may later request V-line treatment, and a submental patient may want arm or flank contouring. Stocking both products under one line captures that upsell naturally.

Swelling in the first several days is a common expected response. Visible fat reduction develops gradually over the following weeks as the body clears the disrupted fat cells. Each session builds on the previous one, and your practitioner will assess progress before scheduling the next treatment.
You will feel a stinging sensation during injection and deep soreness afterward, similar to post-workout muscle ache. Most patients manage comfortably with cold compresses and return to normal activity within a day or two. The V formulation’s extended soothing complex is designed to support a more comfortable recovery in the sensitive facial zone.
Fat cells disrupted by the lipolytic process are not expected to regenerate in the treated area. However, remaining fat cells throughout the body can still expand with significant weight gain. Maintaining a stable weight supports a lasting contouring result.
Correct — glutathione is present in both Body and V. The V formulation differentiates in two ways. First, it adds ingredients that Body does not include: thioredoxin, SOD, acetyl hexapeptide-8, and proprietary botanical soothing complexes, creating a more extensive skin-conditioning profile for the facial treatment zone. Second, V positions glutathione brightening as its headline marketing benefit, giving clinics a clearer product story when presenting V-line services. Combined with the 5 ml facial format, these additions make V the more commercially appropriate choice for facial contouring menus.
Each product is formatted and positioned for its intended treatment context. Body’s 10 ml vial is sized for larger areas and lacks the V formulation’s extended skin-conditioning complex. Using V for large body areas is possible but cost-inefficient given its premium ingredient profile and smaller vial. Match the product to the treatment area for the best balance of efficacy, cost, and patient communication.
Product information cross-referenced across manufacturer product pages and multiple authorized distributors. Product selection, injection protocol, and patient management should follow the supplied product instructions and the practitioner’s clinical judgment.